imipramine has been researched along with Body Weight in 117 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several issues remain to be ascertained beyond the acute response to imipramine hydrochloride in patients with panic disorder." | 9.07 | Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. ( Mavissakalian, M; Perel, JM, 1992) |
| "The study describes a sequential analysis of depression-related physical symptoms and their relationship to imipramine and amitriptyline plasma levels over 4 weeks of treatment in 79 unipolar and bipolar patients hospitalized for major depressive disorder." | 9.07 | The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. ( Bowden, CL; Casper, RC; Davis, JM; Hanin, I; Katz, MM; Koslow, SH, 1994) |
| "To investigate whether imipramine and quinidine, inhibitors of the Na /Mg exchanger, influence development of hypertension in rats infused with angiotensin (Ang) II." | 7.72 | Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats. ( Touyz, RM; Yao, G, 2003) |
| "The selective sigma2 (sigma2) ligand Lu 28-179, or 1'-[4[1-(4-fluorophenyl)-1H-indol-3-yl]-l-butyl]spiro[isobenzofuran++ +-1(3H),4'-piperidine], was studied in the chronic mild stress (CMS) model of depression." | 7.70 | The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. ( Papp, M; Sánchez, C, 2000) |
| " Sprague-Dawley rats with adjuvant-induced arthritis were injected daily for 4 weeks with amitriptyline (10 mg/kg) or imipramine (10 mg/kg) or saline, beginning 21 days after the induction of arthritis." | 7.67 | Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis. ( Besson, JM; Butler, SH; Godefroy, F; Weil-Fugazza, J, 1985) |
| "The authors followed 29 young adults who had been treated for enuresis with imipramine hydrochloride 10 years earlier." | 7.66 | Enuresis treatment with imipramine hydrochloride: a 10-year follow-up study. ( Bindelglas, PM; Dee, G, 1978) |
| "Imipramine is an antidepressant that increases the release of neurotransmitters." | 5.56 | Co-administration of imipramine and doxorubicin reduces the survival rate and body weight of mice. ( Aldubayan, M; Alhowail, A; Chigurupati, S; Elgharabawy, R, 2020) |
| " The results obtained show that the variables which are most associated with the reduction of enuresis are, in decreasing order: the dosage of imipramine administered, the duration of treatment, compliance and the level/dose ratio for the sum of the drug and metabolite levels." | 5.28 | The influence of clinical and pharmacological factors on enuresis treatment with imipramine. ( Domínguez-Gil, A; Fernández de Gatta, MM; Galindo, P; García, MJ; Gutierrez, J; Rey, F; Tamayo, M, 1990) |
| "Several issues remain to be ascertained beyond the acute response to imipramine hydrochloride in patients with panic disorder." | 5.07 | Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. ( Mavissakalian, M; Perel, JM, 1992) |
| "The study describes a sequential analysis of depression-related physical symptoms and their relationship to imipramine and amitriptyline plasma levels over 4 weeks of treatment in 79 unipolar and bipolar patients hospitalized for major depressive disorder." | 5.07 | The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. ( Bowden, CL; Casper, RC; Davis, JM; Hanin, I; Katz, MM; Koslow, SH, 1994) |
| " Three tricyclic antidepressants examined (imipramine, clomipramine and desipramine) did not seem to have the side effect of pathological weight gain in the frequency distribution pattern." | 5.07 | Changes in the frequency distribution pattern of body weight in patients with major depression. ( Kato, T; Murashita, J; Shioiri, T; Takahashi, S; Yamada, N, 1993) |
| " A controlled, double-blind comparison of maprotiline and imipramine in a group of 71 female outpatients with primary depression is presented." | 5.04 | A controlled study of a tetracyclic antidepressant--maprotiline (Ludiomil). ( Holt, NF; Kessell, A, 1975) |
| "In the present study, the amino acids which have the possibility for the therapeutic efficacy of imipramine were explored and compared between Wistar Kyoto rats, an animal model of depression, and Wistar rats as a normal model." | 3.81 | Chronic imipramine treatment differentially alters the brain and plasma amino acid metabolism in Wistar and Wistar Kyoto rats. ( Furuse, M; Nagasawa, M; Otsuka, T; Yasuo, S, 2015) |
| " Using imipramine and citalopram, we sought to assess which drug would be more appropriate as pharmacological reference in paradigms of depression in C57BL6N mice by measuring their effect on liquid consumption, home cage activity, body weight and long-term memory in naïve animals treated with each compound at generally used dose of 15 mg/kg/day." | 3.79 | The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve mice. ( Anokhin, K; Anthony, DC; Dolgov, O; Kubatiev, A; Schroeter, C; Steinbusch, HM; Strekalova, T, 2013) |
| "3 mg kg(-1), intraperitoneal [IP]) for 5 weeks corrected the reduction in body weight gain and sucrose intake induced by CMS." | 3.74 | Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. ( Arguello, O; Bortolato, M; Duranti, A; Fu, J; Kim, JH; Mangieri, RA; Mor, M; Piomelli, D; Tarzia, G; Tontini, A, 2007) |
| "To investigate whether imipramine and quinidine, inhibitors of the Na /Mg exchanger, influence development of hypertension in rats infused with angiotensin (Ang) II." | 3.72 | Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats. ( Touyz, RM; Yao, G, 2003) |
| "In the present in vivo study, we have investigated whether inhibitors of the Na(+)/Mg(2+) exchanger quinidine and imipramine influence the development of hypertension and whether this is associated with modulation of mitogen-activated protein (MAP) kinase activation in arteries and kidneys of hypertensive rats." | 3.72 | Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger. ( Touyz, RM; Yao, G, 2003) |
| "Triiodothyronine (T3) has been shown to accelerate and potentiate the clinical response to tricyclic antidepressant (TCA) treatment in depressive disorders." | 3.71 | Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain. ( Jeanningros, R; Mazzola-Pomietto, P; Moreau, X, 2001) |
| "The selective sigma2 (sigma2) ligand Lu 28-179, or 1'-[4[1-(4-fluorophenyl)-1H-indol-3-yl]-l-butyl]spiro[isobenzofuran++ +-1(3H),4'-piperidine], was studied in the chronic mild stress (CMS) model of depression." | 3.70 | The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. ( Papp, M; Sánchez, C, 2000) |
| " To investigate this phenomenon as a possible animal model of obsessive-compulsive disorder (OCD), rats were treated for 5 weeks with fluoxetine, an antidepressant that relieves OCD symptoms in humans (5 mg/kg, 2." | 3.69 | Effects of serotonergic agents on food-restriction-induced hyperactivity. ( Altemus, M; Galliven, E; Glowa, JR; Leong, YM; Murphy, DL, 1996) |
| " Sprague-Dawley rats with adjuvant-induced arthritis were injected daily for 4 weeks with amitriptyline (10 mg/kg) or imipramine (10 mg/kg) or saline, beginning 21 days after the induction of arthritis." | 3.67 | Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis. ( Besson, JM; Butler, SH; Godefroy, F; Weil-Fugazza, J, 1985) |
| "The effects of daily oral administration of imipramine hydrochloride (5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz-[b,f]azepine monohydrochloride; 50 mg/kg) and/or diazepam (7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one ; 5 mg/kg) in a 1% aqueous solution of carboxymethylcellulose sodium salt (CMC) on the body weight, organ weights, and activities of various enzymes, including drug metabolizing enzyme systems were investigated in rats during a 15-day period." | 3.67 | Effects of combined administration of diazepam and imipramine hydrochloride in rats. ( Igarashi, T; Kitagawa, H; Ohkawara, S; Ohmori, S; Okiyama, M; Ueno, K, 1986) |
| "The interaction of imipramine and operant conditioning on weight gain in an anorexia nervosa patient was examined by a single-subject experiment consisting of a baseline and four treatment phases: phase 1--contingency management only; phase 2--contingency management plus imipramine; phase 3--contingency management plus imipramine placebo; phase 4--contingency management only." | 3.67 | An experimental analysis of the interaction of chemotherapy and behavior therapy in anorexia nervosa. ( Gerner, R; Munford, PR; Tarlow, G, 1984) |
| "The authors followed 29 young adults who had been treated for enuresis with imipramine hydrochloride 10 years earlier." | 3.66 | Enuresis treatment with imipramine hydrochloride: a 10-year follow-up study. ( Bindelglas, PM; Dee, G, 1978) |
| "Measures of subjective feeling used by five patients indicated that depression of mood occurred about four days after fenfluramine withdrawal." | 3.65 | Drugs of dependence though not of abuse: fenfluramine and imipramine. ( Brezinova, V; Briggs, M; Dunleavy, DL; Lewis, SA; Oswald, I, 1971) |
| "The zimeldine treatment group had significantly lower mean HAM-D scale total scores than the placebo and imipramine groups at week 4 and last available assessment." | 2.65 | A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders. ( Feighner, JP; Merideth, CH, 1983) |
| "Methylphenidate-treated children showed significant weight loss but no significant changes in blood pressure or pulse." | 2.64 | Blood pressure and pulse changes in hyperactive children treated with imipramine and methylphenidate. ( Greenberg, LM; Yellin, AM, 1975) |
| "We investigated the effect of chronic administration of fluoxetine "FLU" and imipramine "IMIP" on behavioral, metabolic and vascular abnormalities in diabetic and non-diabetic rats exposed to chronic restraint stress (CRS)." | 1.42 | The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress. ( Aboul-Fotouh, S; El-Gayar, N; Habib, M; Shaker, S, 2015) |
| "Pneumococcal meningitis is a severe infectious disease of the central nervous system, associated with acute inflammation and might cause damage to the host, such as deafness, blindness, seizure, and learning deficits." | 1.38 | Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats. ( Barichello, T; Cipriano, AL; Comim, CM; Costa, CS; Generoso, JS; Milioli, G; Moreira, AP; Quevedo, J; Teixeira, AL; Vilela, MC, 2012) |
| "Depression is a stress related disease, as hormones of the stress-axis can modify mood." | 1.37 | Do stress hormones connect environmental effects with behavior in the forced swim test? ( Domokos, Á; Mergl, Z; Mikics, É; Pintér, O; Zelena, D, 2011) |
| "The treatment with imipramine reversed all the parameters described above." | 1.36 | Depressive-like parameters in sepsis survivor rats. ( Barichello, T; Cassol, OJ; Comim, CM; Constantino, LC; Constantino, LS; Dal-Pizzol, F; Kapczinski, F; Petronilho, F; Quevedo, J; Stertz, L, 2010) |
| "Imipramine treatment reversed the UCMS-induced alterations of the coat state (BALB/c, DBA), in the NSF test (A/J, BALB/c, C57BL/6) and in fecal corticosterone metabolites (BALB/c, C57BL/6)." | 1.35 | Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal. ( Belzung, C; Ibarguen-Vargas, Y; Palme, R; Surget, A; Touma, C, 2008) |
| " A previous study showed that this insensitivity to rewards (anhedonia) could be restored by chronic administration of an antidepressant." | 1.33 | Announced rewards counteract the impairment of anticipatory behaviour in socially stressed rats. ( Baars, AM; Spruijt, BM; van der Harst, JE, 2005) |
| "Treatment with imipramine (10mg/kg i." | 1.33 | Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. ( Antoniou, K; Bekris, S; Daskas, S; Papadopoulou-Daifoti, Z, 2005) |
| " On the 20th day after the start of TD feeding, the increased duration of immobility time induced by TD was shortened by chronic administration of the tricyclic antidepressant imipramine (10 mg/kg, i." | 1.31 | Characteristics of depressive behavior induced by feeding thiamine-deficient diet in mice. ( Esashi, A; Hozumi, S; Kisara, K; Nakagawasai, O; Niijima, F; Tadano, T; Tan-No, K; Taniguchi, R, 2001) |
| "Treatment with imipramine can reduce these behavioural changes but is only effective when given repeatedly prior to onset of CMS." | 1.31 | Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. ( Harkin, A; Houlihan, DD; Kelly, JP, 2002) |
| "Imipramine treatment did not affect the rate of reentrainment after a 6-h advance in the light-dark cycle, did not alter the advanced-phase angle of entrainment of tau-mutant hamsters, did not affect the free-running period of wild type hamsters, and did not alter the phase-response curve to light pulses." | 1.29 | Effects of imipramine on circadian rhythms in the golden hamster. ( Menaker, M; Refinetti, R, 1993) |
| " The results obtained show that the variables which are most associated with the reduction of enuresis are, in decreasing order: the dosage of imipramine administered, the duration of treatment, compliance and the level/dose ratio for the sum of the drug and metabolite levels." | 1.28 | The influence of clinical and pharmacological factors on enuresis treatment with imipramine. ( Domínguez-Gil, A; Fernández de Gatta, MM; Galindo, P; García, MJ; Gutierrez, J; Rey, F; Tamayo, M, 1990) |
| " These findings show that chronic administration of low-modest doses of tricyclic antidepressants frequently cause considerable weight gain and can significantly interfere with the ability to provide long-term maintenance therapy." | 1.27 | Weight gain. A side-effect of tricyclic antidepressants. ( Berken, GH; Stern, WC; Weinstein, DO, 1984) |
| "Imipramine treatment produced a down-regulation of the Bmax for 3H-dihydroalprenolol binding to cortical beta-adrenoceptors that was not dependent upon the time of day the animals were killed." | 1.27 | Cortical beta- and alpha 2- adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamine. ( Ask, AL; Fowler, CJ; Hall, H; Kelder, D; Ross, SB; Sääf, J, 1986) |
| "Imipramine treatment was attempted for nonoverweight patients with negative ear, nose and throat (ENT) findings and for patients who had not responded to weight reduction or ENT surgery (in all patients the apneas were not considered life threatening)." | 1.27 | Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome. ( Alroy, GG; Lavie, P; Peled, R; Rubin, AH, 1986) |
| "Pup body weight was not affected at any age measured, but heart weight was significantly reduced at 10 mg/kg IMI on PNDs 4/5 and 7/8." | 1.27 | Effect of prenatal imipramine exposure on development of the postnatal rat heart and brain. ( Delongchamp, RR; Harmon, JR; Kimmel, GL; Webb, PJ, 1986) |
| " This temporary effect on growth is present during the first few years of treatment and seems related to drug dosage and to the presence or absence of drug holidays." | 1.26 | The effects of stimulant medication on the growth of hyperkinetic children. ( Hung, W; Lipman, RS; Overall, JE; Roche, AF, 1979) |
| "3 Imipramine (Imip) pretreatment before the second trial (10 mg/kg i." | 1.26 | Imipramine normalizes naturally-occurring and drug-induced differences in the exploratory activity of rats. ( Harrison-Read, PE; Steinberg, H, 1980) |
| " Higher levels of gastrointestinal radioactivity (mainly in the stomach lumen) indicated a slower imipramine absorption rate in the subacute group." | 1.26 | Subacute imipramine: changes in single dose pharmacokinetics in rats. ( Beaubien, AR; Huddleston, JA; James, HF; Mathieu, LF, 1977) |
| "In imipramine-treated patients this finding was associated with a decreased rate of drug elimination from plasma." | 1.26 | Relationship between age and tricyclic antidepressant plasma levels. ( Cooper, TB; Friedman, MJ; Green, R; Ives, JO; Nies, A; Ravaris, CL; Robinson, DS, 1977) |
| "Imipramine was used to stimulate a defect in transport of 5-HT observed in the platelets of Duchenne's dystrophy patients." | 1.26 | Imipramine-serotonin induced myopathy. ( Mendell, JR; Olson, WH; Parker, JM; Silverman, LM; Verrill, HL, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 61 (52.14) | 18.7374 |
| 1990's | 18 (15.38) | 18.2507 |
| 2000's | 23 (19.66) | 29.6817 |
| 2010's | 13 (11.11) | 24.3611 |
| 2020's | 2 (1.71) | 2.80 |
| Authors | Studies |
|---|---|
| Alhowail, A | 1 |
| Chigurupati, S | 1 |
| Elgharabawy, R | 1 |
| Aldubayan, M | 1 |
| D'Aquila, PS | 2 |
| Galistu, A | 1 |
| Strekalova, T | 1 |
| Anthony, DC | 1 |
| Dolgov, O | 1 |
| Anokhin, K | 1 |
| Kubatiev, A | 1 |
| Steinbusch, HM | 1 |
| Schroeter, C | 1 |
| Sharma, AN | 1 |
| Ligade, SS | 1 |
| Sharma, JN | 1 |
| Shukla, P | 1 |
| Elased, KM | 1 |
| Lucot, JB | 1 |
| Habib, M | 1 |
| Shaker, S | 1 |
| El-Gayar, N | 1 |
| Aboul-Fotouh, S | 1 |
| Nagasawa, M | 2 |
| Otsuka, T | 1 |
| Yasuo, S | 1 |
| Furuse, M | 2 |
| Alekhina, TA | 1 |
| Palchikova, NA | 1 |
| Igonina, TN | 1 |
| Kuznetsova, NV | 1 |
| Zhang, G | 1 |
| Chen, L | 1 |
| Yang, L | 1 |
| Hua, X | 1 |
| Zhou, B | 1 |
| Miao, Z | 1 |
| Li, J | 2 |
| Hu, H | 1 |
| Namaka, M | 1 |
| Kong, J | 1 |
| Xu, X | 1 |
| Ibarguen-Vargas, Y | 2 |
| Surget, A | 2 |
| Touma, C | 1 |
| Palme, R | 1 |
| Belzung, C | 2 |
| Messaoudi, M | 1 |
| Bisson, JF | 1 |
| Nejdi, A | 1 |
| Rozan, P | 1 |
| Javelot, H | 1 |
| Zafir, A | 1 |
| Ara, A | 1 |
| Banu, N | 1 |
| Green, AD | 1 |
| Barr, AM | 1 |
| Galea, LA | 1 |
| Vourc'h, P | 1 |
| Leman, S | 1 |
| Andres, CR | 1 |
| Gardier, AM | 1 |
| Comim, CM | 2 |
| Cassol, OJ | 1 |
| Constantino, LC | 1 |
| Petronilho, F | 1 |
| Constantino, LS | 1 |
| Stertz, L | 1 |
| Kapczinski, F | 1 |
| Barichello, T | 2 |
| Quevedo, J | 2 |
| Dal-Pizzol, F | 1 |
| Pintér, O | 1 |
| Domokos, Á | 1 |
| Mergl, Z | 1 |
| Mikics, É | 1 |
| Zelena, D | 1 |
| Milioli, G | 1 |
| Generoso, JS | 1 |
| Cipriano, AL | 1 |
| Costa, CS | 1 |
| Moreira, AP | 1 |
| Vilela, MC | 1 |
| Teixeira, AL | 1 |
| Murakami, T | 1 |
| Tomonaga, S | 1 |
| Młyniec, K | 1 |
| Nowak, G | 1 |
| Yu, Y | 1 |
| Wang, R | 1 |
| Chen, C | 1 |
| Du, X | 1 |
| Ruan, L | 1 |
| Sun, J | 1 |
| Zhang, L | 1 |
| O'Donnell, JM | 1 |
| Pan, J | 1 |
| Xu, Y | 1 |
| Krügel, U | 1 |
| Fischer, J | 1 |
| Radicke, S | 1 |
| Sack, U | 1 |
| Himmerich, H | 1 |
| Von Frijtag, JC | 1 |
| Van den Bos, R | 1 |
| Spruijt, BM | 2 |
| Gervasoni, D | 1 |
| Panconi, E | 1 |
| Henninot, V | 1 |
| Boissard, R | 1 |
| Barbagli, B | 1 |
| Fort, P | 1 |
| Luppi, PH | 1 |
| Touyz, RM | 2 |
| Yao, G | 2 |
| Liu, X | 1 |
| Gershenfeld, HK | 1 |
| Duguay, R | 1 |
| Flach, FF | 1 |
| Bekris, S | 1 |
| Antoniou, K | 1 |
| Daskas, S | 1 |
| Papadopoulou-Daifoti, Z | 1 |
| van der Harst, JE | 1 |
| Baars, AM | 1 |
| Panin, F | 1 |
| Castelli, MP | 1 |
| Serra, G | 1 |
| Borsonelo, EC | 1 |
| Galduróz, JC | 1 |
| Suchecki, D | 1 |
| Calil, HM | 1 |
| Bortolato, M | 1 |
| Mangieri, RA | 1 |
| Fu, J | 1 |
| Kim, JH | 1 |
| Arguello, O | 1 |
| Duranti, A | 1 |
| Tontini, A | 1 |
| Mor, M | 1 |
| Tarzia, G | 1 |
| Piomelli, D | 1 |
| Merideth, CH | 1 |
| Feighner, JP | 1 |
| Berken, GH | 1 |
| Weinstein, DO | 1 |
| Stern, WC | 1 |
| Verberne, AJ | 1 |
| Taylor, DA | 1 |
| Fennessy, MR | 1 |
| Bremner, JD | 1 |
| Harrison-Read, PE | 1 |
| Steinberg, H | 1 |
| Crawley, JN | 1 |
| Munford, PR | 1 |
| Tarlow, G | 1 |
| Gerner, R | 1 |
| Olson, EB | 1 |
| Ghias-Ud-Din, M | 1 |
| Rankin, J | 1 |
| Weller, EB | 1 |
| Weller, RA | 1 |
| Preskorn, SH | 1 |
| Glotzbach, R | 1 |
| Peeters, BW | 1 |
| van der Heijden, R | 1 |
| Gubbels, DG | 1 |
| Vanderheyden, PM | 1 |
| Casper, RC | 1 |
| Katz, MM | 1 |
| Bowden, CL | 1 |
| Davis, JM | 1 |
| Koslow, SH | 1 |
| Hanin, I | 1 |
| Mogensen, J | 1 |
| Pedersen, TK | 1 |
| Holm, S | 1 |
| Tejani-Butt, SM | 1 |
| Yang, J | 1 |
| Kaviani, A | 1 |
| Shioiri, T | 1 |
| Kato, T | 1 |
| Murashita, J | 1 |
| Yamada, N | 1 |
| Takahashi, S | 1 |
| Balon, R | 1 |
| Yeragani, VK | 1 |
| Pohl, R | 1 |
| Merlos, B | 1 |
| Sherwood, P | 1 |
| Refinetti, R | 1 |
| Menaker, M | 1 |
| Okuyama, N | 1 |
| Morinobu, S | 1 |
| Totsuka, S | 1 |
| Endoh, M | 1 |
| Altemus, M | 1 |
| Glowa, JR | 1 |
| Galliven, E | 1 |
| Leong, YM | 1 |
| Murphy, DL | 1 |
| Izumi, J | 2 |
| Washizuka, M | 2 |
| Hayashi-Kuwabara, Y | 2 |
| Yoshinaga, K | 2 |
| Tanaka, Y | 2 |
| Ikeda, Y | 2 |
| Kiuchi, Y | 2 |
| Oguchi, K | 2 |
| Rousseau, A | 1 |
| Marquet, P | 1 |
| Lagorce, JF | 1 |
| Sauvage, MF | 1 |
| Buxeraud, J | 1 |
| Lachâtre, G | 1 |
| Raby, C | 1 |
| Cash, TF | 1 |
| Brown, MA | 1 |
| Sánchez, C | 1 |
| Papp, M | 2 |
| Moreau, X | 1 |
| Jeanningros, R | 1 |
| Mazzola-Pomietto, P | 1 |
| Sussman, N | 1 |
| Ginsberg, DL | 1 |
| Bikoff, J | 1 |
| Nakagawasai, O | 1 |
| Tadano, T | 1 |
| Hozumi, S | 1 |
| Taniguchi, R | 1 |
| Tan-No, K | 1 |
| Esashi, A | 1 |
| Niijima, F | 1 |
| Kisara, K | 1 |
| Gittos, MW | 1 |
| Dunn, AJ | 1 |
| Swiergiel, AH | 1 |
| Harkin, A | 1 |
| Houlihan, DD | 1 |
| Kelly, JP | 1 |
| Curtis, LR | 1 |
| Mehendale, HM | 1 |
| Pearlman, C | 1 |
| Becker, M | 1 |
| Broitman, ST | 1 |
| Donoso, AO | 1 |
| Roche, AF | 1 |
| Lipman, RS | 1 |
| Overall, JE | 1 |
| Hung, W | 1 |
| Loullis, CC | 1 |
| Wayner, MJ | 1 |
| Zbinden, G | 1 |
| Elsner, J | 1 |
| Bolliger, H | 1 |
| Anderson, LM | 1 |
| Giner-Sorolla, A | 1 |
| Ebeling, D | 1 |
| Bindelglas, PM | 1 |
| Dee, G | 1 |
| Lauer, JW | 1 |
| Beaubien, AR | 1 |
| Mathieu, LF | 1 |
| Huddleston, JA | 1 |
| James, HF | 1 |
| Nies, A | 1 |
| Robinson, DS | 1 |
| Friedman, MJ | 1 |
| Green, R | 1 |
| Cooper, TB | 1 |
| Ravaris, CL | 1 |
| Ives, JO | 1 |
| Mendell, JR | 1 |
| Silverman, LM | 1 |
| Verrill, HL | 1 |
| Parker, JM | 1 |
| Olson, WH | 1 |
| Quinn, PO | 1 |
| Rapoport, JL | 1 |
| Kessell, A | 2 |
| Holt, NF | 2 |
| Greenberg, LM | 1 |
| Yellin, AM | 1 |
| Hayes, TA | 1 |
| Panitch, ML | 1 |
| Barker, E | 1 |
| Kita, T | 1 |
| Hata, T | 1 |
| Okage, T | 1 |
| Yoneda, R | 1 |
| Hoshino, K | 1 |
| Shibuya, T | 1 |
| Matsuda, H | 1 |
| Endo, T | 1 |
| Chen, PO | 1 |
| Sato, K | 1 |
| Nishimori, T | 1 |
| Holt, KG | 1 |
| Mavissakalian, M | 1 |
| Perel, JM | 1 |
| Schultz, JE | 1 |
| Rösch, H | 1 |
| Brady, LS | 1 |
| Whitfield, HJ | 1 |
| Fox, RJ | 1 |
| Gold, PW | 1 |
| Herkenham, M | 1 |
| Fernández de Gatta, MM | 1 |
| Galindo, P | 1 |
| Rey, F | 1 |
| Gutierrez, J | 1 |
| Tamayo, M | 1 |
| García, MJ | 1 |
| Domínguez-Gil, A | 1 |
| Mitchell, JE | 1 |
| Pyle, RL | 1 |
| Eckert, ED | 1 |
| Hatsukami, D | 1 |
| Pomeroy, C | 1 |
| Zimmerman, R | 1 |
| Massol, J | 1 |
| Martin, P | 1 |
| Brochet, D | 1 |
| Belon, JP | 1 |
| Puech, AJ | 1 |
| Cohen, BM | 1 |
| Zubenko, GS | 1 |
| Harmon, JR | 1 |
| Webb, PJ | 1 |
| Kimmel, GL | 1 |
| Delongchamp, RR | 1 |
| Ask, AL | 1 |
| Fowler, CJ | 1 |
| Hall, H | 1 |
| Kelder, D | 1 |
| Ross, SB | 1 |
| Sääf, J | 1 |
| Levine, S | 1 |
| Deo, R | 1 |
| Mahadevan, K | 1 |
| Fernstrom, MH | 4 |
| Kupfer, DJ | 4 |
| Krowinski, RL | 2 |
| Hughes, RN | 1 |
| Pither, JM | 1 |
| Okiyama, M | 1 |
| Ueno, K | 1 |
| Ohkawara, S | 1 |
| Ohmori, S | 1 |
| Igarashi, T | 1 |
| Kitagawa, H | 1 |
| Cohn, JB | 1 |
| Wilcox, C | 1 |
| Rubin, AH | 1 |
| Alroy, GG | 1 |
| Peled, R | 1 |
| Lavie, P | 1 |
| Rabkin, JG | 1 |
| Quitkin, FM | 1 |
| McGrath, P | 1 |
| Harrison, W | 1 |
| Tricamo, E | 1 |
| Epstein, LH | 1 |
| Spiker, DG | 1 |
| Butler, SH | 1 |
| Weil-Fugazza, J | 1 |
| Godefroy, F | 1 |
| Besson, JM | 1 |
| Frazer, A | 1 |
| Pandey, G | 1 |
| Mendels, J | 1 |
| Neeley, S | 1 |
| Kane, M | 1 |
| Hess, ME | 1 |
| Opitz, K | 1 |
| Akinlaja, A | 1 |
| Gluckman, MI | 1 |
| Baum, T | 1 |
| Pradhan, SN | 1 |
| Ray, P | 1 |
| Watt, DC | 1 |
| Crammer, JL | 1 |
| Elkes, A | 1 |
| Tsegos, IK | 1 |
| Ekdawi, MY | 1 |
| Kaneto, H | 1 |
| Koida, M | 1 |
| Tsuchie, F | 1 |
| Caron, LB | 1 |
| Gauthier, R | 1 |
| Pinard, G | 1 |
| Gagnon, MA | 1 |
| Tétreault, L | 1 |
| Stern, JJ | 1 |
| Zwick, G | 1 |
| Pearce, TA | 1 |
| Oswald, I | 1 |
| Lewis, SA | 1 |
| Dunleavy, DL | 1 |
| Brezinova, V | 1 |
| Briggs, M | 1 |
| Nissen, G | 1 |
| Spilimbergo, A | 1 |
| Aeppli, L | 1 |
| Schimmelbusch, WH | 1 |
| Mueller, PS | 1 |
| Sheps, J | 1 |
| Iwaki, R | 1 |
| Kudo, Y | 1 |
| Ishiko, J | 1 |
| Irikura, T | 1 |
| Porter, AM | 1 |
| Prange, AJ | 2 |
| Bakewell, WE | 2 |
| Widmann, FK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? A Randomized, Double-blinded, Placebo-controlled Clinical Trial[NCT01845259] | Phase 2 | 103 participants (Actual) | Interventional | 2013-04-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for imipramine and Body Weight
| Article | Year |
|---|---|
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Controlled | 2001 |
19 trials available for imipramine and Body Weight
| Article | Year |
|---|---|
Antidepressant effects of TNF-α blockade in an animal model of depression.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Body Weight; Depression; Disease Models, Anima | 2013 |
A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Blood Pressure; Body Weight; Clinical Trials as Topic; De | 1983 |
Fluoxetine in depressed patients: a comparison with imipramine.
Topics: Adult; Aged; Ambulatory Care; Body Weight; Clinical Trials as Topic; Depressive Disorder; Double-Bli | 1984 |
The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine.
Topics: Adult; Affect; Amitriptyline; Appetite; Arousal; Bipolar Disorder; Body Weight; Depressive Disorder; | 1994 |
Changes in the frequency distribution pattern of body weight in patients with major depression.
Topics: Adult; Antidepressive Agents, Tricyclic; Body Weight; Clomipramine; Depressive Disorder; Desipramine | 1993 |
Changes in appetite and weight during the pharmacological treatment of patients with panic disorder.
Topics: Adult; Agoraphobia; Appetite; Body Weight; Diazepam; Dietary Carbohydrates; Double-Blind Method; Fem | 1993 |
Attitudes about antidepressants: influence of information about weight-related side effects.
Topics: Adolescent; Adult; Antidepressive Agents; Attitude to Health; Body Weight; Drug Information Services | 2000 |
The effect of tricyclic antidepressant compounds on patients with passive-dependent personality traits.
Topics: Adult; Antidepressive Agents, Tricyclic; Body Weight; Clinical Trials as Topic; Dependency, Psycholo | 1976 |
One-year follow-up of hyperactive boys treated with imipramine or methylphenidate.
Topics: Administration, Oral; Body Weight; Child Behavior Disorders; Clinical Trials as Topic; Drug Evaluati | 1975 |
A controlled study of a tetracyclic antidepressant--maprotiline (Ludiomil).
Topics: Adjustment Disorders; Adult; Anthracenes; Bipolar Disorder; Body Weight; Clinical Trials as Topic; D | 1975 |
Blood pressure and pulse changes in hyperactive children treated with imipramine and methylphenidate.
Topics: Adolescent; Blood Pressure; Body Weight; Child; Clinical Trials as Topic; Drug Evaluation; Female; H | 1975 |
Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Blood Pressure; Body Weight; Double-Blind Method; Drug Administration Schedule; | 1992 |
A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Anxiety; Behavior Therapy; Body Weight; Bulimia; Cognitive Beha | 1990 |
A comparative trial of a new antidepressant, fluoxetine.
Topics: Adult; Aged; Body Weight; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female | 1987 |
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Topics: Adult; Ambulatory Care; Anxiety; Body Weight; Clinical Trials as Topic; Depressive Disorder; Dizzine | 1985 |
Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness.
Topics: Adult; Aged; Body Weight; Clinical Trials as Topic; Depression; Desipramine; Dose-Response Relations | 1972 |
A double-blind controlled study of viloxazine and imipramine in depression.
Topics: Adult; Antidepressive Agents; Blood Pressure; Body Weight; Clinical Trials as Topic; Depression; Eth | 1974 |
A controlled study of nortriptyline and imipramine.
Topics: Anxiety; Body Weight; Clinical Trials as Topic; Depression; Female; Humans; Imipramine; Nortriptylin | 1970 |
Body height and imipramine side-effects.
Topics: Adipose Tissue; Adult; Body Height; Body Weight; Female; Genes; Humans; Imipramine; Male | 1968 |
97 other studies available for imipramine and Body Weight
| Article | Year |
|---|---|
Co-administration of imipramine and doxorubicin reduces the survival rate and body weight of mice.
Topics: Animals; Body Weight; Doxorubicin; Drug Therapy, Combination; Female; Imipramine; Injections, Intrap | 2020 |
Further characterization of the effect of the prototypical antidepressant imipramine on the microstructure of licking for sucrose.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Dri | 2021 |
The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cita | 2013 |
GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Body Weight; Chole | 2015 |
The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Blood Pressure; Blood Vessels; Body | 2015 |
Chronic imipramine treatment differentially alters the brain and plasma amino acid metabolism in Wistar and Wistar Kyoto rats.
Topics: Amino Acids; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Brain; Depres | 2015 |
[Comparative analysis of imipramine intake reactions in catatonic and wistar rats].
Topics: Acoustic Stimulation; Animals; Body Weight; Catatonia; Corpus Striatum; Corticosterone; Imipramine; | 2015 |
Combined use of spatial restraint stress and middle cerebral artery occlusion is a novel model of post-stroke depression in mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Brain; Brain-Derived Neuro | 2015 |
Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Body Weight; Depression; Explorato | 2008 |
Antidepressant-like effects of a cocoa polyphenolic extract in Wistar-Unilever rats.
Topics: Animals; Antidepressive Agents; Body Weight; Cacao; Flavonoids; Imipramine; Immobility Response, Ton | 2008 |
Invivo antioxidant status: a putative target of antidepressant action.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tri | 2009 |
Role of estradiol withdrawal in 'anhedonic' sucrose consumption: a model of postpartum depression.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Body Weight; Depression, Postpartum; Disease M | 2009 |
Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress.
Topics: Aggression; Animals; Antidepressive Agents, Tricyclic; Anxiety; Body Weight; Brain-Derived Neurotrop | 2009 |
Depressive-like parameters in sepsis survivor rats.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Analysis of Variance; Animals; Antidepressive Agents, T | 2010 |
Do stress hormones connect environmental effects with behavior in the forced swim test?
Topics: Adaptation, Psychological; Adrenocorticotropic Hormone; Animals; Behavior, Animal; Body Temperature; | 2011 |
Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Anhedonia; Animals; Antidepressive Agents, Tricyclic; B | 2012 |
The impact of chronic imipramine treatment on amino acid concentrations in the hippocampus of mice.
Topics: Amino Acids; Animals; Antidepressive Agents, Tricyclic; Body Weight; Brain Chemistry; Cerebral Corte | 2012 |
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Body Weight; Citalopram; Depression; Drug Resistan | 2012 |
Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences.
Topics: Adrenal Glands; Animals; Antidepressive Agents; Body Weight; Brain; Chronic Disease; Disease Models, | 2013 |
Imipramine restores the long-term impairment of appetitive behavior in socially stressed rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Appetitive Behavior; Body Weight; Imipramine; Male; Rats; | 2002 |
Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agen | 2002 |
Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats.
Topics: Angiotensin II; Animals; Antiporters; Biological Transport; Blood Platelets; Blood Pressure; Body We | 2003 |
Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger.
Topics: Angiotensin II; Animals; Antiporters; Blood Pressure; Body Weight; Hypertension; Imipramine; Kidney | 2003 |
An exploratory factor analysis of the Tail Suspension Test in 12 inbred strains of mice and an F2 intercross.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Body Temperature Regulation; Body Weight; C | 2003 |
AN EXPERIMENTAL STUDY OF WEIGHT CHANGES IN DEPRESSIONS.
Topics: Bipolar Disorder; Body Weight; Calcium; Calcium, Dietary; Depression; Diet; Drug Therapy; Electrocon | 1964 |
Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Beh | 2005 |
Announced rewards counteract the impairment of anticipatory behaviour in socially stressed rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Appetitive Behavior; Behavior, Anim | 2005 |
Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Dopamine; Electrophysiolog | 2006 |
The influence of n-6 fatty acid supplemented diet on the effect of imipramine in an animal model of depression.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Catecholamines; Chromatography, High Pressur | 2007 |
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
Topics: Amidohydrolases; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Weight; Brain; C | 2007 |
Weight gain. A side-effect of tricyclic antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Appetite; Body Weight; Depressive Disorder; | 1984 |
Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
Topics: Animals; Biogenic Amines; Body Weight; Clomipramine; Dronabinol; Eating; Fluoxetine; Humans; Imipram | 1980 |
Imipramine normalizes naturally-occurring and drug-induced differences in the exploratory activity of rats.
Topics: 5-Hydroxytryptophan; Animals; Body Weight; Drug Interactions; Exploratory Behavior; Female; Fencloni | 1980 |
Evaluation of a proposed hamster separation model of depression.
Topics: Animals; Behavior, Animal; Body Weight; Cricetinae; Depression; Disease Models, Animal; Exploratory | 1984 |
An experimental analysis of the interaction of chemotherapy and behavior therapy in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Behavior Therapy; Body Weight; Combined Modality Therapy; Conditioning, Ope | 1984 |
Serotonin uptake and metabolism in isolated, perfused fetal, newborn and adult rabbit lungs.
Topics: Animals; Animals, Newborn; Body Weight; Fetus; Imipramine; Lung; Organ Size; Perfusion; Pulmonary We | 1983 |
Steady-state plasma imipramine levels in prepubertal depressed children.
Topics: Age Factors; Body Height; Body Weight; Child; Depressive Disorder; Desipramine; Humans; Imipramine; | 1982 |
Effects of chronic antidepressant treatment on the hypothalamic-pituitary-adrenal axis of Wistar rats.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Body Weight; Corticosterone; Hippocampus; | 1994 |
Effects of chronic imipramine on exploration, locomotion, and food/water intake in rats.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Drinking; Eating; Exploratory Behavior; Groo | 1994 |
Time course of altered thyroid states on 5-HT1A receptors and 5-HT uptake sites in rat brain: an autoradiographic analysis.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoradiography; Body Weight; Brain Chemistry; Hype | 1993 |
Effects of imipramine on circadian rhythms in the golden hamster.
Topics: Animals; Body Temperature; Body Weight; Circadian Rhythm; Cricetinae; Darkness; Imipramine; Light; M | 1993 |
Enhancement of 5-hydroxytryptamine-stimulated phosphoinositide hydrolysis in the rat cerebral cortex by repeated immobilization stress.
Topics: Animals; Body Weight; Cerebral Cortex; Hydrolysis; Imipramine; Immobilization; Ketanserin; Male; Pho | 1995 |
Effects of serotonergic agents on food-restriction-induced hyperactivity.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Disease Models, Animal; Eating; Female; Fenc | 1996 |
Protective effect of citalopram against the attenuation of the alpha 1-potentiation of cAMP formation in Fischer 344 strain rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Citalopram; C | 1997 |
Evidence for a depressive-like state induced by repeated saline injections in Fischer 344 rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Depressive Disorder; Emotions; Handling, Psy | 1997 |
Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Desipramine; Imipramine; Male; Rats; Rats, W | 1998 |
The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricy | 2000 |
Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Tricyclic; Body Weight; Brai | 2001 |
Characteristics of depressive behavior induced by feeding thiamine-deficient diet in mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Depression; Diet; Disease | 2001 |
Antidepressant-like action of AGN 2979, a tryptophan hydroxylase activation inhibitor, in a chronic mild stress model of depression in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Depression; Enzyme Inhibitors; Imipramine; M | 2001 |
The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Appetite; Body Weight; Brain; Cyclohex | 2001 |
Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Consummatory Behavior; Drinking; Grooming; H | 2002 |
The effects of kepone pretreatment on biliary excretion of xenobiotics in the male rat.
Topics: Adenosine Triphosphatases; Animals; Bile; Body Weight; Chlordecone; Eating; Imipramine; Insecticides | 1979 |
Retroactive impairment of cooperative learning by imipramine and chlordiazepoxide in rats.
Topics: Animals; Body Weight; Chlordiazepoxide; Cooperative Behavior; Feeding Behavior; Female; Imipramine; | 1975 |
Effects of chronic imipramine and clomipramine oral administration on maternal behavior and litter development.
Topics: Animals; Body Weight; Clomipramine; Dibenzazepines; Female; Growth; Imipramine; Maternal Behavior; M | 1978 |
The effects of stimulant medication on the growth of hyperkinetic children.
Topics: Adolescent; Body Height; Body Weight; Child Behavior Disorders; Dextroamphetamine; Growth; Growth Di | 1979 |
Effects of imipramine on schedule dependent and schedule induced behavior.
Topics: Animals; Body Weight; Conditioning, Operant; Dose-Response Relationship, Drug; Drinking Behavior; Dr | 1979 |
Toxicological evaluation of imipramine in combination with adriamycin and strophanthin.
Topics: Animals; Body Weight; Doxorubicin; Drug Interactions; Electrocardiography; Female; Heart; Imipramine | 1977 |
Effects of imipramine, nitrite, and dimethylnitrosamine on reproduction in mice.
Topics: Animals; Birth Weight; Body Weight; Dimethylnitrosamine; Drug Interactions; Female; Fertility; Imipr | 1978 |
Enuresis treatment with imipramine hydrochloride: a 10-year follow-up study.
Topics: Adaptation, Psychological; Adolescent; Adult; Body Height; Body Weight; Child; Child Development; En | 1978 |
Subacute imipramine: changes in single dose pharmacokinetics in rats.
Topics: Administration, Oral; Animals; Bile; Biotransformation; Body Weight; Imipramine; Intestinal Absorpti | 1977 |
Relationship between age and tricyclic antidepressant plasma levels.
Topics: Administration, Oral; Adult; Age Factors; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Bod | 1977 |
Imipramine-serotonin induced myopathy.
Topics: Animals; Aspartate Aminotransferases; Biogenic Amines; Body Weight; Creatine Kinase; Dose-Response R | 1976 |
Imipramine dosage in children: a comment on "imipramine and electrocardiographic abnormalities in hyperactive children".
Topics: Adult; Age Factors; Animals; Atrioventricular Node; Body Weight; Child; Child Behavior Disorders; Dr | 1975 |
[Effect of neurotropin on SART stress (stress caused by alteration of rhythms in environmental temperature) in mice and rats].
Topics: Acetylcholine; Aminobutyrates; Animals; Body Weight; Chlorpromazine; Diazepam; Diphenhydramine; Duod | 1975 |
Pharmacological studies of drug action on CNS, with special reference to effects of maprotiline.
Topics: Action Potentials; Amitriptyline; Animals; Anthracenes; Antiemetics; Apomorphine; Body Weight; Cats; | 1975 |
Growth deficits and desipramine.
Topics: Appetite; Attention Deficit Disorder with Hyperactivity; Body Weight; Child; Depressive Disorder; De | 1992 |
Differential effects of ovarian steroid hormones on beta-adrenoceptor downregulation caused by the antidepressants imipramine and rolipram.
Topics: Animals; Antidepressive Agents; Body Weight; Cerebral Cortex; Down-Regulation; Estrone; Female; Gona | 1991 |
Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Corticosterone; Corticotropin-Rel | 1991 |
The influence of clinical and pharmacological factors on enuresis treatment with imipramine.
Topics: Adolescent; Age Factors; Body Weight; Child; Child, Preschool; Desipramine; Enuresis; Female; Humans | 1990 |
Are antidepressant-like effects of triiodothyronine (T3) in rodents related to an hyperthyroid state?
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Apomorphine; Avoidance Learning; Body Temperatu | 1989 |
In vivo effects of psychotropic agents on the physical properties of cell membranes in the rat brain.
Topics: Animals; Antipsychotic Agents; Body Weight; Brain; Cell Membrane; Diphenylhexatriene; Fluorescence P | 1985 |
Effect of prenatal imipramine exposure on development of the postnatal rat heart and brain.
Topics: Aging; Animals; Body Weight; Brain; Dihydroalprenolol; Eflornithine; Female; Heart; Imipramine; Litt | 1986 |
Cortical beta- and alpha 2- adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamine.
Topics: Alanine; Animals; Antidepressive Agents; Body Weight; Cerebral Cortex; Circadian Rhythm; Dihydroalpr | 1986 |
Imipramine treatment and preference for sweets.
Topics: Adult; Body Weight; Depressive Disorder; Dietary Carbohydrates; Dietary Fats; Female; Food Preferenc | 1988 |
Appetite and food preference in depression: effects of imipramine treatment.
Topics: Adult; Appetite; Body Weight; Depressive Disorder; Female; Food Preferences; Humans; Imipramine; Mal | 1987 |
Chronic imipramine effects on exploratory behavior in rats.
Topics: Animals; Body Weight; Exploratory Behavior; Female; Grooming; Imipramine; Male; Motor Activity; Rats | 1987 |
Chronic imipramine treatment and weight gain.
Topics: Adult; Aged; Appetite; Body Weight; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Ag | 1986 |
Effects of combined administration of diazepam and imipramine hydrochloride in rats.
Topics: Animals; Body Weight; Diazepam; Enzymes; Imipramine; Kinetics; Male; Microsomes, Liver; Organ Size; | 1986 |
Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome.
Topics: Adult; Body Weight; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Protriptyline; | 1986 |
Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
Topics: Adult; Bipolar Disorder; Body Weight; Erectile Dysfunction; Female; Humans; Hypertension; Imipramine | 1985 |
Resting metabolic rate is reduced in patients treated with antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents; Body Weight; Depressive Disorder; Drug Therapy, Combina | 1985 |
Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis.
Topics: Amitriptyline; Animals; Arthritis; Arthritis, Experimental; Behavior, Animal; Body Weight; Disease M | 1985 |
The effect of tri-iodothyronine in combination with impramine on [3H]-cyclic AMP production in slices of rat cerebral cortex.
Topics: Animals; Body Weight; Cerebral Cortex; Chromatography; Cyclic AMP; Dose-Response Relationship, Drug; | 1974 |
[On the influencing of food intake by psychotropic drugs].
Topics: Amitriptyline; Animals; Behavior, Animal; Body Weight; Central Nervous System; Central Nervous Syste | 1966 |
The pharmacology of iprindole, a new antidepressant.
Topics: Acetylcholine; Amitriptyline; Amphetamine; Animals; Antidepressive Agents; Appetite; Atropine; Bleph | 1969 |
Effects of stress on growth of transplanted and 7,12-dimethylbenz(alpha)anthracene-induced tumors and their modification by psychotropic drugs.
Topics: Adrenal Glands; Animals; Benz(a)Anthracenes; Body Weight; Chlorpromazine; Electroshock; Female; Huma | 1974 |
[Tolerance and physical dependence producing liability of doxepin].
Topics: Amitriptyline; Animals; Body Weight; Diazepam; Dibenzoxepins; Drug Resistance; Humans; Imipramine; M | 1972 |
[Influence of dibencycladine and imipramine on the caloric intake and body weight].
Topics: Acute Disease; Anthracenes; Antidepressive Agents; Body Weight; Depression; Feeding Behavior; Female | 1973 |
Effects of intraventricular norepinephrine and estradiol benzoate on weight regulatory behavior in female rats.
Topics: Animals; Body Weight; Brain Chemistry; Castration; Cerebral Ventricles; Darkness; Drug Synergism; Ea | 1973 |
Drugs of dependence though not of abuse: fenfluramine and imipramine.
Topics: Adult; Appetite Depressants; Body Weight; Depression; Dreams; Female; Fenfluramine; Fluorine; Humans | 1971 |
[On the symptoms and therapy of depressive diseases diagnosed in early childhood].
Topics: Aggression; Body Weight; Child Behavior Disorders; Child, Preschool; Depression; Electroencephalogra | 1970 |
[Teratologic studies with imipramine in rats and rabbits. Planning and interpretation of teratologic studies under consideration of the biochemistry and toxicology of test substance].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Animals; Body Weight; Desipramine; Drug Toleranc | 1969 |
The positive correlation between insulin resistance and duration of hospitalization in untreated schizophrenia.
Topics: Adult; Age Factors; Blood Glucose; Body Weight; Chronic Disease; Fatty Acids, Nonesterified; Growth | 1971 |
[Differences on blood pressure responses to drugs in hypertensive and normotensive rats. (1)].
Topics: Animals; Atropine; Azoles; Blood Pressure; Body Weight; Caffeine; Carbamates; Chlorothiazide; Diuret | 1967 |
Effects of imipramine and reserpine on body size and organ size in euthyroid and hyperthyroid growing rats.
Topics: Animals; Body Weight; Growth; Heart; Hyperthyroidism; Imipramine; In Vitro Techniques; Kidney; Liver | 1966 |
Variable density of silver-stained fibrils in the myocardium.
Topics: Animals; Body Weight; Heart; Imipramine; Male; Myocardium; Organ Size; Rats; Reserpine; Thyroxine | 1966 |